NCT05793632View on ClinicalTrials.gov

Quetiapine in Prevention of Delirium

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

April 1, 2023

Study Completion Date

April 15, 2023

Conditions
Delirium
Interventions
DRUG

Quetiapine

The patients will be randomly divided into two equal groups group Q and group C. Randomization will be done by computer-generated number lists and using opaque sealed envelopes.

Trial Locations (1)

Unknown

Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER